Cargando…

Correlation of FDG‐PET hypometabolism and SEEG epileptogenicity mapping in patients with drug‐resistant focal epilepsy

OBJECTIVE: Interictal [18F]fluorodeoxyglucose–positron emission tomography (FDG‐PET) is used in the presurgical evaluation of patients with drug‐resistant focal epilepsy. We aimed at clarifying its relationships with ictal high‐frequency oscillations (iHFOs) shown to be a relevant marker of the seiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamarche, Florence, Job, Anne‐Sophie, Deman, Pierre, Bhattacharjee, Manik, Hoffmann, Dominique, Gallazzini‐Crépin, Céline, Bouvard, Sandrine, Minotti, Lorella, Kahane, Philippe, David, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214566/
https://www.ncbi.nlm.nih.gov/pubmed/27861778
http://dx.doi.org/10.1111/epi.13592
_version_ 1782491637182627840
author Lamarche, Florence
Job, Anne‐Sophie
Deman, Pierre
Bhattacharjee, Manik
Hoffmann, Dominique
Gallazzini‐Crépin, Céline
Bouvard, Sandrine
Minotti, Lorella
Kahane, Philippe
David, Olivier
author_facet Lamarche, Florence
Job, Anne‐Sophie
Deman, Pierre
Bhattacharjee, Manik
Hoffmann, Dominique
Gallazzini‐Crépin, Céline
Bouvard, Sandrine
Minotti, Lorella
Kahane, Philippe
David, Olivier
author_sort Lamarche, Florence
collection PubMed
description OBJECTIVE: Interictal [18F]fluorodeoxyglucose–positron emission tomography (FDG‐PET) is used in the presurgical evaluation of patients with drug‐resistant focal epilepsy. We aimed at clarifying its relationships with ictal high‐frequency oscillations (iHFOs) shown to be a relevant marker of the seizure‐onset zone. METHODS: We studied the correlation between FDG‐PET and epileptogenicity maps in an unselected series of 37 successive patients having been explored with stereo‐electroencephalography (SEEG). RESULTS: At the group level, we found a significant correlation between iHFOs and FDG‐PET interictal hypometabolism only in cases of temporal lobe epilepsy. This correlation was found with HFOs, and the same comparison between FDG‐PET and ictal SEEG power of lower frequencies during the same epochs did not show the same significance. SIGNIFICANCE: This finding suggests that interictal FDG‐PET and ictal HFOs may share common underlying pathophysiologic mechanisms of ictogenesis in temporal lobe epilepsy, and combining both features may help to identify the seizure‐onset zone.
format Online
Article
Text
id pubmed-5214566
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-52145662017-01-18 Correlation of FDG‐PET hypometabolism and SEEG epileptogenicity mapping in patients with drug‐resistant focal epilepsy Lamarche, Florence Job, Anne‐Sophie Deman, Pierre Bhattacharjee, Manik Hoffmann, Dominique Gallazzini‐Crépin, Céline Bouvard, Sandrine Minotti, Lorella Kahane, Philippe David, Olivier Epilepsia Full‐length Original Research OBJECTIVE: Interictal [18F]fluorodeoxyglucose–positron emission tomography (FDG‐PET) is used in the presurgical evaluation of patients with drug‐resistant focal epilepsy. We aimed at clarifying its relationships with ictal high‐frequency oscillations (iHFOs) shown to be a relevant marker of the seizure‐onset zone. METHODS: We studied the correlation between FDG‐PET and epileptogenicity maps in an unselected series of 37 successive patients having been explored with stereo‐electroencephalography (SEEG). RESULTS: At the group level, we found a significant correlation between iHFOs and FDG‐PET interictal hypometabolism only in cases of temporal lobe epilepsy. This correlation was found with HFOs, and the same comparison between FDG‐PET and ictal SEEG power of lower frequencies during the same epochs did not show the same significance. SIGNIFICANCE: This finding suggests that interictal FDG‐PET and ictal HFOs may share common underlying pathophysiologic mechanisms of ictogenesis in temporal lobe epilepsy, and combining both features may help to identify the seizure‐onset zone. John Wiley and Sons Inc. 2016-11-08 2016-12 /pmc/articles/PMC5214566/ /pubmed/27861778 http://dx.doi.org/10.1111/epi.13592 Text en © 2016 The Authors. Epilepsia published by Wiley Periodicals, Inc. on behalf of International League Against Epilepsy. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Full‐length Original Research
Lamarche, Florence
Job, Anne‐Sophie
Deman, Pierre
Bhattacharjee, Manik
Hoffmann, Dominique
Gallazzini‐Crépin, Céline
Bouvard, Sandrine
Minotti, Lorella
Kahane, Philippe
David, Olivier
Correlation of FDG‐PET hypometabolism and SEEG epileptogenicity mapping in patients with drug‐resistant focal epilepsy
title Correlation of FDG‐PET hypometabolism and SEEG epileptogenicity mapping in patients with drug‐resistant focal epilepsy
title_full Correlation of FDG‐PET hypometabolism and SEEG epileptogenicity mapping in patients with drug‐resistant focal epilepsy
title_fullStr Correlation of FDG‐PET hypometabolism and SEEG epileptogenicity mapping in patients with drug‐resistant focal epilepsy
title_full_unstemmed Correlation of FDG‐PET hypometabolism and SEEG epileptogenicity mapping in patients with drug‐resistant focal epilepsy
title_short Correlation of FDG‐PET hypometabolism and SEEG epileptogenicity mapping in patients with drug‐resistant focal epilepsy
title_sort correlation of fdg‐pet hypometabolism and seeg epileptogenicity mapping in patients with drug‐resistant focal epilepsy
topic Full‐length Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214566/
https://www.ncbi.nlm.nih.gov/pubmed/27861778
http://dx.doi.org/10.1111/epi.13592
work_keys_str_mv AT lamarcheflorence correlationoffdgpethypometabolismandseegepileptogenicitymappinginpatientswithdrugresistantfocalepilepsy
AT jobannesophie correlationoffdgpethypometabolismandseegepileptogenicitymappinginpatientswithdrugresistantfocalepilepsy
AT demanpierre correlationoffdgpethypometabolismandseegepileptogenicitymappinginpatientswithdrugresistantfocalepilepsy
AT bhattacharjeemanik correlationoffdgpethypometabolismandseegepileptogenicitymappinginpatientswithdrugresistantfocalepilepsy
AT hoffmanndominique correlationoffdgpethypometabolismandseegepileptogenicitymappinginpatientswithdrugresistantfocalepilepsy
AT gallazzinicrepinceline correlationoffdgpethypometabolismandseegepileptogenicitymappinginpatientswithdrugresistantfocalepilepsy
AT bouvardsandrine correlationoffdgpethypometabolismandseegepileptogenicitymappinginpatientswithdrugresistantfocalepilepsy
AT minottilorella correlationoffdgpethypometabolismandseegepileptogenicitymappinginpatientswithdrugresistantfocalepilepsy
AT kahanephilippe correlationoffdgpethypometabolismandseegepileptogenicitymappinginpatientswithdrugresistantfocalepilepsy
AT davidolivier correlationoffdgpethypometabolismandseegepileptogenicitymappinginpatientswithdrugresistantfocalepilepsy